Santa Cruz Biotechnology provides a broad selection of HNF-1 monoclonal antibodies for investigating HNF-1 in various biological processes. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).HNF-1, or Hepatocyte Nuclear Factor 1, is a critical transcription factor involved in the regulation of genes essential for liver and kidney function. HNF-1 plays a significant role in glucose metabolism and is implicated in the development of diabetes and other metabolic disorders. Understanding HNF-1 function is vital for elucidating its contributions to various diseases and for developing targeted therapeutic strategies. Research has shown that mutations in HNF-1 can lead to maturity-onset diabetes of the young (MODY), highlighting its importance in metabolic regulation. HNF-1 also influences the expression of genes involved in drug metabolism and transport, making it relevant for pharmacological studies. Recent studies have revealed new roles for HNF-1 in embryonic development and cellular differentiation. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of HNF-1's role in human health and disease.